These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 9819787)
1. Hormone replacement therapy and urinary prostaglandins in postmenopausal women. Akgül C; Canbaz M; Vural P; Yildirim A; Geren N Maturitas; 1998 Sep; 30(1):79-83. PubMed ID: 9819787 [TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy to improve left ventricular diastolic functions in healthy postmenopausal women. Yildirir A; Yarali H; Kabakci G; Aybar F; Akgul E; Bukulmez O Int J Gynaecol Obstet; 2001 Dec; 75(3):273-8. PubMed ID: 11728489 [TBL] [Abstract][Full Text] [Related]
3. Effects of hormone replacement therapy on plasma nitric oxide and total thiol levels in postmenopausal women. Konukoğlu D; Serin O; Yelke HK J Toxicol Environ Health A; 2000 May; 60(2):81-7. PubMed ID: 10872630 [TBL] [Abstract][Full Text] [Related]
4. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH JAMA; 2002 May 22-29; 287(20):2668-76. PubMed ID: 12020302 [TBL] [Abstract][Full Text] [Related]
5. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison. Pan HA; Wang ST; Pai MC; Chen CH; Wu MH; Huang KE J Reprod Med; 2003 May; 48(5):375-80. PubMed ID: 12815913 [TBL] [Abstract][Full Text] [Related]
6. The effects of postmenopausal hormone replacement therapy on sympathetic skin response. Sahiner T; Aktan E; Kaleli B; Oguzhanoglu A Maturitas; 1998 Sep; 30(1):85-8. PubMed ID: 9819788 [TBL] [Abstract][Full Text] [Related]
7. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women. Edlefsen KL; Jackson RD; Prentice RL; Janssen I; Rajkovic A; O'Sullivan MJ; Anderson G Menopause; 2010; 17(3):622-9. PubMed ID: 20215977 [TBL] [Abstract][Full Text] [Related]
8. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women. Vural P; Akgul C; Canbaz M Pharmacol Res; 2006 Oct; 54(4):298-302. PubMed ID: 16879975 [TBL] [Abstract][Full Text] [Related]
9. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women. Orr-Walker BJ; Evans MC; Clearwater JM; Horne A; Grey AB; Reid IR Arch Intern Med; 2000 Jul; 160(14):2161-6. PubMed ID: 10904459 [TBL] [Abstract][Full Text] [Related]
10. The effects of estradiol valerate plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women. Egarter C; Geurts P; Boschitsch E; Speiser P; Huber J Acta Obstet Gynecol Scand; 1996 Apr; 75(4):386-93. PubMed ID: 8638462 [TBL] [Abstract][Full Text] [Related]
11. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women]. Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174 [TBL] [Abstract][Full Text] [Related]
12. Impact of calcitonin on urinary excretion of prostaglandins during menopause. Akgül C; Vural P; Canbaz M Gynecol Obstet Invest; 1998; 46(3):199-201. PubMed ID: 9736804 [TBL] [Abstract][Full Text] [Related]
13. Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women. Lamon-Fava S; Posfai B; Schaefer EJ Am J Cardiol; 2003 Jan; 91(2):252-4. PubMed ID: 12521647 [No Abstract] [Full Text] [Related]
14. [The effects of hormone replacement therapy on pulmonary functions in postmenopausal women]. Köksal N; Güven A; Celik O; Kiran G; Kiran H; Ekerbiçer HC Tuberk Toraks; 2004; 52(3):237-42. PubMed ID: 15351936 [TBL] [Abstract][Full Text] [Related]
15. Fatty acid composition of serum phospholipid of premenopausal women and postmenopausal women receiving and not receiving hormone replacement therapy. Stark KD; Park EJ; Holub BJ Menopause; 2003; 10(5):448-55. PubMed ID: 14501607 [TBL] [Abstract][Full Text] [Related]
16. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. Hlatky MA; Boothroyd D; Vittinghoff E; Sharp P; Whooley MA; JAMA; 2002 Feb; 287(5):591-7. PubMed ID: 11829697 [TBL] [Abstract][Full Text] [Related]
17. How many women lose bone mineral density while taking hormone replacement therapy? Results from the Postmenopausal Estrogen/Progestin Interventions Trial. Greendale GA; Wells B; Marcus R; Barrett-Connor E Arch Intern Med; 2000 Nov; 160(20):3065-71. PubMed ID: 11074735 [TBL] [Abstract][Full Text] [Related]
18. Effect of hormone replacement therapy on uterine fibroids in postmenopausal women--a 3-year study. Yang CH; Lee JN; Hsu SC; Kuo CH; Tsai EM Maturitas; 2002 Sep; 43(1):35-9. PubMed ID: 12270580 [TBL] [Abstract][Full Text] [Related]
19. Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels. Yildirir A; Aybar F; Tokgozoglu L; Yarali H; Kabakci G; Bukulmez O; Sinici I; Oto A Gynecol Obstet Invest; 2002; 53(1):54-8. PubMed ID: 11803230 [TBL] [Abstract][Full Text] [Related]
20. Quantification of ovarian stromal Doppler signals in postmenopausal women receiving hormone replacement therapy. Pan HA; Li CH; Cheng YC; Wu MH; Chang FM Menopause; 2003; 10(4):366-72. PubMed ID: 12851521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]